Approved in May 2019, granted to FoldRx, a subsidiary of Pfizer.
Kevin Luong, PharmD Candidate 2021
Advertisement
Articles by Kevin Luong, PharmD Candidate 2021
Advertisement
Latest Updated Articles
New Drug Review: Tafamidis Meglumine for CardiomyopathyPublished: October 24th 2019 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Leading Cause of Meningitis Shifts from S. Pneumoniae to K. Pneumoniae
2
American Pharmacists Month: Evolution of Experiential Learning for Pharmacy Students
3
Pharmacists Improve Diabetes Outcomes Through Continuous Glucose Monitoring Services
4
Finerenone in HFpEF and HFmrEF: Emerging Evidence and Guideline Updates
5
